Overall rank by patents
#3,892
Across all tracked assignees
USPTO PatentsView assignee record - 93 granted patents across 28 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01M (CATCHING, TRAPPING OR SCARING OF ANIMALS ; APPARATUS FOR THE DESTRUCTION OF NOXIOUS ANIMALS OR NOXIOUS PLANTS).
The verdict
OMS holds 93 US patents across 28 technology areas, rank #3,892 of 50,000 tracked assignees.
OMS Investments, Inc. has been granted 93 US utility patents between 2015 and 2025, placing OMS Investments, Inc. at rank #3,892 across all assignees tracked by PlainPatent. This portfolio spans 28 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.8 claims per patent with primary concentration in A01M (CATCHING, TRAPPING OR SCARING OF ANIMALS ; APPARATUS FOR THE DESTRUCTION OF NOXIOUS ANIMALS OR NOXIOUS PLANTS). As a US Corporation, OMS Investments, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, OMS sits between Korea Basic Science Institute (93 patents, rank #3,888) and Sandoz Ag (93 patents, rank #3,896) - the closest US assignees by grant volume. The composite Innovation Score of 46.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 53 grants, compared with 40 in the 2015–2019 window, a +33% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. OMS Investments, Inc.'s 10.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 28 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark OMS Investments, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
KOREA BASIC SCIENCE INSTITUTE
93 patents
LG CNS CO., LTD.
93 patents
Labrador Diagnostics LLC
93 patents
Novomer, Inc.
93 patents
Overhead Door Corporation
93 patents
SONAR AUTO PARTS CO., LTD.
93 patents
SUPERC-TOUCH CORPORATION
93 patents
Sandoz AG
93 patents
OMS Investments, Inc.
93 patents
What this shows OMS holds 93 patents at rank #3,892, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,892 in granted patent volume.
Other assignees with the most granted patents in OMS's primary technology class.
OMS's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 10 | 10.8% |
| 2016 | 6 | 6.5% |
| 2017 | 6 | 6.5% |
| 2018 | 5 | 5.4% |
| 2019 | 13 | 14.0% |
| 2020 | 8 | 8.6% |
| 2021 | 12 | 12.9% |
| 2022 | 12 | 12.9% |
| 2023 | 7 | 7.5% |
| 2024 | 7 | 7.5% |
| 2025 | 7 | 7.5% |
Top 15 of 28 technology areas
Overall rank by patents
#3,892
Across all tracked assignees
46.1 out of 100
How to use this portfolio
OMS's 93 grants land it in the top 22% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.